Connection
Prasad Padala to Depressive Disorder
This is a "connection" page, showing publications Prasad Padala has written about Depressive Disorder.
|
|
Connection Strength |
|
|
|
|
|
1.723 |
|
|
|
-
Padala PR, Padala KP, Majagi AS, Garner KK, Dennis RA, Sullivan DH. Selective serotonin reuptake inhibitors-associated apathy syndrome: A cross sectional study. Medicine (Baltimore). 2020 Aug 14; 99(33):e21497.
Score: 0.600
-
Padala KP, Parkes CM, Padala PR. Neuropsychological and Functional Impact of COVID-19 on Mild Cognitive Impairment. Am J Alzheimers Dis Other Demen. 2020 Jan-Dec; 35:1533317520960875.
Score: 0.575
-
Padala PR, Burke WJ, Bhatia SC. Modafinil therapy for apathy in an elderly patient. Ann Pharmacother. 2007 Feb; 41(2):346-9.
Score: 0.235
-
Padala KP, Padala PR, Leung YK, Dennis RA, Ho SM. Open Burn Pit Exposure and Concern About the COVID-19 Pandemic. Prim Care Companion CNS Disord. 2020 11 05; 22(6).
Score: 0.152
-
Padala PR, Padala KP, Monga V, Ramirez DA, Sullivan DH. Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. Ann Pharmacother. 2012 Mar; 46(3):e8.
Score: 0.083
-
Warsi MK, Sattar SP, Din AU, Petty F, Padala PR. Are medical students assigning proper global assessment of functioning scores? Acad Psychiatry. 2007 Jan-Feb; 31(1):51-6.
Score: 0.058
-
Padala KP, Padala PR, Malloy T, Burke WJ. New onset multimodal hallucinations associated with mirtazapine: a case report. Int Psychogeriatr. 2010 Aug; 22(5):837-9.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|